As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/12/21  Revance Therapeutics, Inc.        8-K:1,2      4/6/21   12:171K                                                            
  4/6/21  Rankin Aubrey                     4          Dir.,Off.²  1:5K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    

____________
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.